HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Double-blind pretreatment of exercise-induced asthma with sequential inhalations of fenoterol from an aerosol and as a powder (second of two parts).

AbstractEighteen adult asthmatics participated in a placebo controlled, double-blind, randomised study comparing the efficacy of pretreatment with fenoterol administered by pressurized aerosol and as a dry powder on exercise-induced asthma. The dosages used were 0.6 mg and 1.0 mg as both pressurized aerosol and dry powder. The pretreatment was given over a period of 10 min. Six min of treadmill-running was performed in a climate chamber 30 min after pretreatment on five successive days. The lung function was assessed by peak expiratory rate. The decrease in lung function following pretreatment with placebo was 32% (average +/- (SEM) (2). Falls of 9% (2) and 8% (1) were seen after pretreatment with 0.6 and 1.0 mg from a pressurized aerosol. The falls following pretreatment with 0.6 and 1.0 mg of dry powder were 8% (2) and 8%, respectively. It is concluded that pretreatment of exercise-induced asthma with a beta-2-agonist is equally effective whether dosed from a pressurized aerosol as when given as a dry powder. A dose of 0.6 mg is just as effective as a dose of 1.0 mg when inhaled over a period of ten min.
AuthorsA Bundgaard, A Schmidt
JournalEuropean journal of respiratory diseases. Supplement (Eur J Respir Dis Suppl) Vol. 130 Pg. 66-72 ( 1983) ISSN: 0106-4347 [Print] DENMARK
PMID6360704 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Aerosols
  • Ethanolamines
  • Powders
  • Fenoterol
Topics
  • Adult
  • Aerosols
  • Asthma (prevention & control)
  • Asthma, Exercise-Induced (prevention & control)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Ethanolamines (administration & dosage)
  • Female
  • Fenoterol (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Powders

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD